Simon Nicholas 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Jun 6, 2012
Insider Transaction Report
Form 4
Simon Nicholas
Director10% Owner
Transactions
- Other
Common Stock
2012-06-04+22,078→ 22,078 total(indirect: By Trust) - Other
Common Stock
2012-06-04+51,515→ 51,515 total
Footnotes (1)
- [F1]Distribution of shares in kind by Clarus Lifesciences II, L.P. (the "Fund"). In prior reports, the Reporting Person reported that he may be deemed to beneficially own shares held of record by the Fund. As a result of the distribution of shares in kind, the Reporting Person now holds the reported shares directly.